-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Evaxion Biotech (EVAX)
-
-
-
-
-
-
-
MSD declines option on Evaxion's gonorrhea vaccine candidate
-
-
-
-
-
-
-
Evaxion Biotech registers 769,000 ADSs for selling shareholder
-
-
-
-
-
-
-
Evaxion launches automated vaccine design module for AI platform
-
-
-
-
-
-
-
Evaxion Biotech (EVAX) Misses Q1 EPS by 1c
-
-
-
-
-
-
-
Evaxion Biotech (EVAX) to implement ADS ratio change
-
-
-
-
-
-
-
Evaxion Biotech (EVAX): Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology platform
-
479,041 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


